TY - JOUR
T1 - Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse
AU - Hoffmann, Céline
AU - Filali, Liza
AU - Wurzer, Hannah
AU - Fernandes, Diogo Pereira
AU - Mgrditchian, Takouhie
AU - Huang, Wanxin
AU - Moreau, Flora
AU - Krecké, Max
AU - Thomas, Clément
N1 - Funding:
Clément Thomas’s group is supported by the Luxembourg National Research Fund (FNR) and La Fondation Cancer, Luxembourg
(C21/BM/15752542/SYNAPODIA and FC/2019/02/ACTIMMUNE), as well as by
Think Pink Luxembourg, Luxembourg (Marian Aldred Award). Hannah Wurzer and Wanxin Huang are recipients of PhD fellowships from the Luxembourg FNR (FNR; PRIDE15/10675146/CANBIO and PRIDE21/16763386/CANBIO2, respectively).
Diogo Pereira Fernandes and Max Krecké hold PhD fellowships from the Fonds
de la Recherche Scientifique (FNRS), Belgium (Télévie 7.4594.23 and 7.4531.20,
respectively). Takouhie Mgrditchian is the recipient of a postdoctoral fellowship
from the FNRS, Belgium (Télévie 7.4597.22). We acknowledge the National
Cytometry Platform (NCP) for assistance in generating cytometry data; the NCP
is funded by Luxembourg’s Ministry of Higher Education and Research.
Publisher Copyright:
Copyright © 2025 the Author(s).
PY - 2025/8/12
Y1 - 2025/8/12
N2 - Natural killer (NK) cells engage target cells via the immunological synapse (IS), where inhibitory and activating signals determine whether NK cell cytotoxicity is suppressed or activated. We previously reported that cancer cells can rapidly remodel their actin cytoskeleton upon NK cell engagement, leading to F-actin accumulation at the synapse. Here, we show that this process inhibits NK cell activation as indicated by impaired MTOC and lytic granule polarization. Exploring the underlying mechanism, we demonstrate that actin remodeling drives the recruitment of inhibitory ligands, such as HLA-A, -B, and -C, to the synapse. Disrupting HLA interaction with their cognate inhibitory receptors KIRs restores NK cell activation. Using NK cells expressing inhibitory KIR receptors, matched or unmatched to HLA molecules on cancer cells, we show that synaptic F-actin accumulation and matching KIR–HLA interactions jointly suppress NK cell cytotoxicity. Our findings reveal an immune evasion strategy in which cancer cells impair NK cell activation by altering synaptic signaling through actin cytoskeleton–driven recruitment of inhibitory signals to the IS.
AB - Natural killer (NK) cells engage target cells via the immunological synapse (IS), where inhibitory and activating signals determine whether NK cell cytotoxicity is suppressed or activated. We previously reported that cancer cells can rapidly remodel their actin cytoskeleton upon NK cell engagement, leading to F-actin accumulation at the synapse. Here, we show that this process inhibits NK cell activation as indicated by impaired MTOC and lytic granule polarization. Exploring the underlying mechanism, we demonstrate that actin remodeling drives the recruitment of inhibitory ligands, such as HLA-A, -B, and -C, to the synapse. Disrupting HLA interaction with their cognate inhibitory receptors KIRs restores NK cell activation. Using NK cells expressing inhibitory KIR receptors, matched or unmatched to HLA molecules on cancer cells, we show that synaptic F-actin accumulation and matching KIR–HLA interactions jointly suppress NK cell cytotoxicity. Our findings reveal an immune evasion strategy in which cancer cells impair NK cell activation by altering synaptic signaling through actin cytoskeleton–driven recruitment of inhibitory signals to the IS.
KW - actin cytoskeleton
KW - cancer
KW - immunological synapse
KW - natural killer
KW - Killer Cells, Natural/immunology
KW - Actin Cytoskeleton/metabolism
KW - Actins/metabolism
KW - Signal Transduction
KW - Humans
KW - Receptors, KIR/metabolism
KW - Lymphocyte Activation/immunology
KW - Cell Line, Tumor
KW - Immunological Synapses/immunology
KW - Ligands
KW - Neoplasms/immunology
KW - HLA Antigens/immunology
KW - Cytotoxicity, Immunologic
UR - https://www.scopus.com/pages/publications/105013074878
UR - https://pubmed.ncbi.nlm.nih.gov/40763024/
U2 - 10.1073/pnas.2503259122
DO - 10.1073/pnas.2503259122
M3 - Article
C2 - 40763024
AN - SCOPUS:105013074878
SN - 0027-8424
VL - 122
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 32
M1 - e2503259122
ER -